Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood

Endocrinology

Volumn 152, Issue 2, 2011, Pages 618-628

  Roland, Alison V ^a   Moenter, Suzanne M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GONADORELIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LUTEINIZING HORMONE; METFORMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ESTRUS CYCLE; FEMALE; IN VIVO STUDY; MOUSE; NERVE CELL; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; VIRILIZATION;

ANIMALS; DIHYDROTESTOSTERONE; ELECTROPHYSIOLOGY; ESTROUS CYCLE; FEMALE; GLUCOSE TOLERANCE TEST; GONADOTROPIN-RELEASING HORMONE; METFORMIN; MICE; MICE, TRANSGENIC; NEURONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 79951627782     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0823     Document Type: Article

References (82)

1. Wildt L, Hausler A, Marshall G, Hutchison JS, Plant TM, Belchetz PE, Knobil E 1981 Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology 109:376-385 (Pubitemid 11040187)
2. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2248-2256 (Pubitemid 27287593)
3. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley Jr WF 1988 Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocri Metab 66:165-172 (Pubitemid 18027747)
4. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 57:1320-1329
5. Blank SK, McCartney CR, Marshall JC 2006 The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 12:351-361 (Pubitemid 43923410)
6. Abbott DH, Barnett DK, Bruns CM, Dumesic DA 2005 Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 11:357-374
7. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Pérez-Bravo F, Recabarren SE 2002 Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 17:2573-2579 (Pubitemid 35174106)
8. Dumesic DA, Abbott DH, Padmanabhan V 2007 Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 8:127-141
9. Sullivan SD, Moenter SM 2004 Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc Natl Acad Sci USA 101:7129-7134 (Pubitemid 38596454)
10. Roland AV, Nunemaker CS, Keller SR, Moenter SM 2010 Prenatal androgen exposure programs metabolic dysfunction in female mice. J Endocrinol 207:213-223
11. DeFazio RA, Heger S, Ojeda SR, Moenter SM 2002 Activation of A-type γ-aminobutyric acid receptors excites gonadotropin-releasing hormone neurons. Mol Endocrinol 16:2872-2891 (Pubitemid 36020664)
12. Sarma HN, Manikkam M, Herkimer C, Dell'Orco J, Welch KB, Foster DL, Padmanabhan V 2005 Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female. Endocrinology 146:4281-4291
13. Masek KS, Wood RI, Foster DL 1999 Prenatal dihydrotestosterone differentially masculinizes tonic and surge modes of luteinizing hormone secretion in sheep. Endocrinology 140:3459-3466 (Pubitemid 30645401)
14. Foecking EM, Szabo M, Schwartz NB, Levine JE 2005 Neuro-endocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biol Reprod 72:1475-1483 (Pubitemid 40696090)
15. DeUgarte CM, Bartolucci AA, Azziz R 2005 Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83:1454-1460 (Pubitemid 40615820)
16. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257-1266
17. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800 (Pubitemid 28009567)
18. Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A 1998 Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 138:269-274 (Pubitemid 28154775)
19. Palomba S, Falbo A, Zullo F, Orio Jr F 2009 Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 30:1-50
20. Essah PA, Apridonidze T, Iuorno MJ, Nestler JE 2006 Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril 86:230-232 (Pubitemid 43962958)
21. Palomba S, Orio Jr F, Falbo A, Manguso F, Russo T, Cascella T, Tolino A, Carmina E, Colao A, Zullo F 2005 Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4068-4074 (Pubitemid 41058174)
22. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ 1994 Met-formin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43:647-654 (Pubitemid 24145474)
23. Romualdi D, Giuliani M, Cristello F, Fulghesu AM, Selvaggi L, Lanzone A, Guido M 2010 Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Fertil Steril 93:2303-2310
24. Tan S, Hahn S, Benson S, Dietz T, Lahner H, Moeller LC, Schmidt M, Elsenbruch S, Kimmig R, Mann K, Janssen OE 2007 Metformin improves polycystic ovary syndrome symptoms irrespective of pretreatment insulin resistance. Eur J Endocrinol 157:669-676 (Pubitemid 350187385)
25. Romualdi D, Costantini B, Selvaggi L, Giuliani M, Cristello F, Macrì F, Bompiani A, Lanzone A, Guido M 2008 Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective. Hum Reprod 23:2127-2133
26. Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM 2007 Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol 23:146-152 (Pubitemid 46570211)
27. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE 2001 Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174 (Pubitemid 32995375)
28. Winder WW, Hardie DG 1999 AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277:E1-E10 (Pubitemid 29356721)
29. Tosca L, Solnais P, Ferré P, Foufelle F, Dupont J 2006 Metformin-induced stimulation of adenosine 5′ monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells. Biol Reprod 75:342-351 (Pubitemid 44268068)
30. Tosca L, Chabrolle C, Uzbekova S, Dupont J 2007 Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5′ monophosphate-activated protein kinase (AMPK). Biol Reprod 76:368-378
31. Richardson MC, Ingamells S, Simonis CD, Cameron IT, Sreekumar R, Vijendren A, Sellahewa L, Coakley S, Byrne CD 2009 Stimulation of lactate production in human granulosa cells by metformin and potential involvement of adenosine 5′ monophosphate-activated protein kinase. J Clin Endocrinol Metab 94:670-677
32. Kayampilly PP, Menon KM 2009 Follicle-stimulating hormone inhibits adenosine 5′-monophosphate-activated protein kinase activation and promotes cell proliferation of primary granulosa cells in culture through an Akt-dependent pathway. Endocrinology 150: 929-935
33. Lu M, Tang Q, Olefsky JM, Mellon PL, Webster NJ 2008 Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LβT2 gonadotropes. Mol Endocrinol 22:760-771 (Pubitemid 351397801)
34. Ramamurthy S, Ronnett GV 2006 Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J Physiol 574:85-93 (Pubitemid 43905799)
35. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S 2009 AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem 109(Suppl 1):17-23
36. Ropelle ER, Pauli JR, Zecchin KG, Ueno M, de Souza CT, Morari J, Faria MC, Velloso LA, Saad MJ, Carvalheira JB 2007 A central role for neuronal adenosine 5′-monophosphate-activated protein kinase in cancer-induced anorexia. Endocrinology 148:5220-5229 (Pubitemid 350012623)
37. Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran TH, Ronnett GV 2004 C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J Biol Chem 279:19970-19976 (Pubitemid 38623439)
38. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferré P, Birnbaum MJ, Stuck BJ, Kahn BB 2004 AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428:569-574 (Pubitemid 38480541)
39. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D, Small CJ 2004 AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279:12005-12008 (Pubitemid 38445761)
40. Suter KJ, Song WJ, Sampson TL, Wuarin JP, Saunders JT, Dudek FE, Moenter SM 2000 Genetic targeting of green fluorescent protein to gonadotropin-releasing hormone neurons: characterization of whole-cell electrophysiological properties and morphology. Endocrinology 141:412-419 (Pubitemid 32260384)
41. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R 2008 Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol 199: 596-609
42. Bergheim I, Guo L, Davis MA, Lambert JC, Beier JI, Duveau I, Luyendyk JP, Roth RA, Arteel GE 2006 Metformin prevents alcohol- induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1. Gastroenterology 130:2099-2112 (Pubitemid 43816952)
43. Heishi M, Ichihara J, Teramoto R, Itakura Y, Hayashi K, Ishikawa H, Gomi H, Sakai J, Kanaoka M, Taiji M, Kimura T 2006 Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin. Diabetologia 49:1647-1655 (Pubitemid 43848102)
44. Hou M, Venier N, Sugar L, Musquera M, Pollak M, Kiss A, Fleshner N, Klotz L, Venkateswaran V 2010 Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet. Biochem Biophys Res Commun 397:537-542
45. Brill DS, Moenter SM 2009 Androgen receptor antagonism and an insulin sensitizer block the advancement of vaginal opening by highfat diet in mice. Biol Reprod 81:1093-1098
46. Nunemaker CS, DeFazio RA, Moenter SM 2002 Estradiol-sensitive afferents modulate long-term episodic firing patterns of GnRH neurons. Endocrinology 143:2284-2292 (Pubitemid 34521575)
47. Chu Z, Moenter SM 2005 Endogenous activation of metabotropic glutamate receptors modulates GABAergic transmission to gonadotropin- releasing hormone neurons and alters their firing rate: a possible local feedback circuit. J Neurosci 25:5740-5749 (Pubitemid 40847886)
48. Nunemaker CS, DeFazio RA, Moenter SM 2003 A targeted extracellular approach for recording long-term firing patterns of excitable cells: a practical guide. Biol Proced Online 5:53-62 (Pubitemid 38097499)
49. Matteri RL, Roser JF, Baldwin DM, Lipovetsky V, Papkoff H 1987 Characterization of a monoclonal antibody which detects luteinizing hormone from diverse mammalian species. Domest Anim Endocrinol 4:157-165
50. Haavisto AM, Pettersson K, Bergendahl M, Perheentupa A, Roser JF, Huhtaniemi I 1993 A supersensitive immunofluorometric assay for rat luteinizing hormone. Endocrinology 132:1687-1691 (Pubitemid 23110543)
51. Fallest PC, Trader GL, Darrow JM, Shupnik MA 1995 Regulation of rat luteinizing hormone β gene expression in transgenic mice by steroids and a gonadotropin-releasing hormone antagonist. Biol Reprod 53:103-109
52. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE 1995 Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333:550-554
53. Dutton A, Dyball RE 1979 Phasic firing enhances vasopressin release from the rat neurohypophysis. J Physiol 290:433-440 (Pubitemid 9194163)
54. Roland AV, Moenter SM 2010 Role of AMP-activated protein kinase (AMPK) in glucosensing by gonadotropin-releasing hormone (GnRH) neurons. 40th Annual Meeting of The Society for Neuroscience, San Diego, CA, 2010 (Abstract 6326)
55. Shim WS, Conaway M, Masamura S, Yue W, Wang JP, Kmar R, Santen RJ 2000 Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo. Endocrinology 141:396-405 (Pubitemid 32260382)
56. Coyral-Castel S, Tosca L, Ferreira G, Jeanpierre E, Rame C, Lomet D, Caraty A, Monget P, Chabrolle C, Dupont J 2008 The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats. J Neuroendocrinol 20:335-346 (Pubitemid 351280097)
57. Fujii N, Jessen N, Goodyear LJ 2006 AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 291:E867-E877
58. Falbo A, Orio F, Venturella R, Rania E, Materazzo C, Tolino A, Zullo F, Palomba S 2009 Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis. J Ovarian Res 2:5
59. Ozcimen EE, Uckuyu A, Ciftci FC, Zeyneloglu HB 2009 The effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome. Arch Gynecol Obstet 280:263-269
60. Palomba S, Orio Jr F, Falbo A, Russo T, Tolino A, Zullo F 2006 Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome. Fertil Steril 86:1694-1701
61. Mansfield R, Galea R, Brincat M, Hole D, Mason H 2003 Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril 79:956-962 (Pubitemid 36385020)
62. Attia GR, Rainey WE, Carr BR 2001 Metformin directly inhibits androgen production in human thecal cells. Fertil Steril 76:517-524
63. Pielecka J, Quaynor SD, Moenter SM 2006 Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback. Endocrinology 147:1474-1479 (Pubitemid 43244382)
64. Matthaei S, Reibold JP, Hamann A, Benecke H, Häring HU, Greten H, Klein HH 1993 In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. Endocrinology 133:304-311
65. Bourron O, Daval M, Hainault I, Hajduch E, Servant JM, Gautier JF, Ferré P, Foufelle F 2010 Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia 53:768-778
66. Jakubowska J, Bohdanowicz-Pawlak A, Milewicz A, Szymczak J, Bednarek-Tupikowska G, Demissie M 2008 Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Gynecol Endocrinol 24:378-384 (Pubitemid 352032225)
67. Huypens P, Quartier E, Pipeleers D, Van de Casteele M 2005 Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase. Eur J Pharmacol 518:90-95 (Pubitemid 41133630)
68. Rea R, Donnelly R 2006 Effects of metformin and oleic acid on adipocyte expression of resistin. Diabetes Obes Metab 8:105-109
69. Mueller WM, Stanhope KL, Gregoire F, Evans JL, Havel PJ 2000 Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obes Res 8:530-539
70. Klein J, Westphal S, Kraus D, Meier B, Perwitz N, Ott V, Fasshauer M, Klein HH 2004 Metformin inhibits leptin secretion via a mitogen- activated protein kinase signalling pathway in brown adipocytes. J Endocrinol 183:299-307 (Pubitemid 39562712)
71. He G, Pedersen SB, Bruun JM, Lihn AS, Richelsen B 2003 Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro. Horm Metab Res 35:18-23 (Pubitemid 36403287)
72. Pan W, Kastin AJ 2007 Adipokines and the blood-brain barrier. Peptides 28:1317-1330 (Pubitemid 46843398)
73. Ahima RS 2005 Central actions of adipocyte hormones. Trends Endocrinol Metab 16:307-313 (Pubitemid 41206637)
74. Wen JP, Lv WS, Yang J, Nie AF, Cheng XB, Yang Y, Ge Y, Li XY, Ning G 2008 Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochem Biophys Res Commun 371:756-761 (Pubitemid 351728105)
75. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI, Lodish HF, Ruderman NB 2002 Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99:16309-16313 (Pubitemid 35462791)
76. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295 (Pubitemid 35373562)
77. Zhou L, Deepa SS, Etzler JC, Ryu J, Mao X, Fang Q, Liu DD, Torres JM, Jia W, Lechleiter JD, Liu F, Dong LQ 2009 Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/ LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways. J Biol Chem 284:22426-22435
78. Oride A, Kanasaki H, Purwana IN, Miyazaki K 2010 Effects of metformin administration on plasma gonadotropin levels in women with infertility, with an in vitro study of the direct effects on the pituitary gonadotrophs. Pituitary 13:236-241
79. Genazzani AD, Battaglia C, Malavasi B, Strucchi C, Tortolani F, Gamba O 2004 Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil Steril 81:114-119 (Pubitemid 38058335)
80. Sahin Y, Unluhizarci K, Yilmazsoy A, Yikilmaz A, Aygen E, AQKelestimur F 2007 The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome. Clin Endocrinol 67:904-908 (Pubitemid 350135135)
81. Zhou R, Bruns CM, Bird IM, Kemnitz JW, Goodfriend TL, Dumesic DA, Abbott DH 2007 Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod Toxicol 23:438-448 (Pubitemid 46602932)
82. Veiga-Lopez A, Lee JS, Padmanabhan V 2010 Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep. Endocrinology 151:4007-4017